PRIMARY HEALTH PROPERTIES PLC - CANCELLATION OF S524806 Unaudited interim results for the six months ended 30 June 2026
What this filing means
Net rental income surged 123% to £176m, reflecting the Assura combination, while adjusted EPS rose 9% to 3.8p and the dividend was lifted 3% to 3.65p — respectable headline numbers. But HEPS was flat at 3.2p and EPS fell 14%, so the revenue growth has not yet translated into per-share earnings improvement. With available liquidity more than halved to £301m and the balance sheet requiring active deleveraging through asset sales and JV structures, this is a case where size grew faster than value — the deal boosted the top line, but the market had partially priced that story in advance and the per-share picture is the more important signal underneath.
PHP doubled its rental income by combining with another company, but the share count grew too, so the profit per share barely moved. Meanwhile, the company's available cash more than halved, leaving it dependent on selling assets or finding joint-venture partners to pay down debt. The dividend went up slightly, but not by enough to ignore the tighter liquidity cushion. Think of it as a company that got much bigger on paper without yet getting better for shareholders.
Bull case
- Net rental income more than doubled (+123%) to £176m, reflecting the Assura combination's scale benefits.
- Adjusted EPS rose 9% to 3.8p, evidencing underlying earnings growth beyond just the enlarged asset base.
- Dividend per share lifted 3% to 3.65p with adjusted-earnings coverage improving to 103%.
- Management reiterates focus on synergy capture and asset disposals/JVs to manage leverage post-Assura.
Bear case
- HEPS held flat at 3.2p despite net rental income surging 123% to £176m, indicating the Assura combination has yet to deliver per-share earnings accretion.
- Available liquidity more than halved to £301m from £571m, leaving the group heavily reliant on refinancing the balance of the acquisition facility.
- Dividend coverage sits at only 1.03x of adjusted earnings, a thin buffer as average cost of debt edges up to 3.8% from 3.7%.
- Reported EPS fell 14% to 3.8p on non-cash property revaluation and interest-rate derivative losses, signalling underlying book value erosion.
- Liquidity stress: Total undrawn loan facilities and cash of £301 million (December 2025: £571 million)
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
A two-tier result: the top line is legitimately strong (123% rental income growth, 9% adjusted EPS), but the per-share metrics tell a more cautious story. HEPS flat despite a 123% revenue uplift means the Assura combination enlarged the business without lifting returns per share — a deleveraging story more than an expansion story. The dividend edge-up is genuine but covered by only 1.03x adjusted earnings, a thin buffer as funding costs edge up. With the liquidity buffer halved and a refinancing runway ahead, the balance sheet is the constraint to watch. The 5.5% run-in means the market had already started pricing the deal-driven growth narrative, which limits the upside from here. So what: the headline numbers validate the Assura deal's scale but not yet its per-share value creation — the market needs to see the deleveraging plan execute before it can re-rate the name. Missing evidence: No prior trading statement range to assess beat/miss; No share count or weighted average shares disclosed in short form; No cash flow statement or covenant compliance details; No quantified synergy targets or timeline for leverage reduction; No segment breakdown of UK vs Ireland or private hospital pipeline contribution
The H2 results and any disclosed disposal or JV programme will be where the market tests whether the liquidity gap closes and whether per-share earnings finally start growing.
Evidence from the filing
Net rental income more than doubled (+123%) to £176m, reflecting the Assura combination's scale benefits.
“Net rental income increased by 123% to £176 million (June 2025: £79 million)”
Adjusted EPS rose 9% to 3.8p, evidencing underlying earnings growth beyond just the enlarged asset base.
“Adjusted earnings per share (see note 1) increased by 9% to 3.8 pence (June 2025: 3.54 pence)”
Dividend per share lifted 3% to 3.65p with adjusted-earnings coverage improving to 103%.
“Dividend per share increased by 3% to 3.65 pence (June 2025: 3.55 pence) and remains fully covered by adjusted earnings at 103% (June 2025: 100%)”
Management reiterates focus on synergy capture and asset disposals/JVs to manage leverage post-Assura.
“The immediate focus of the business remains on delivering the strategic benefits and priorities following the combination with Assura: managing leverage through moving assets into joint ventures or sales, integrating the two businesses whilst continuing to deliver further cost and operating synergy benefits, and refinancing the balance of the acquisition facility.”
HEPS held flat at 3.2p despite net rental income surging 123% to £176m, indicating the Assura combination has yet to deliver per-share earnings accretion.
“Headline earnings per share ('HEPS') (see note 2) maintained at 3.2 pence (June 2025: 3.2 pence)”
Available liquidity more than halved to £301m from £571m, leaving the group heavily reliant on refinancing the balance of the acquisition facility.
“Total undrawn loan facilities and cash of £301 million (December 2025: £571 million)”
Reported EPS fell 14% to 3.8p on non-cash property revaluation and interest-rate derivative losses, signalling underlying book value erosion.
“Earnings per share ('EPS') decreased by 14% to 3.8 pence (June 2025: 4.4 pence)”
Filing provides only unaudited interim figures with no cash-flow statement, segment breakdown, or detailed debt-maturity profile to verify sustainability.
“Unaudited interim results for the six months ended 30 June 2026”
More on Primary Health Prop PLC
Related filings
More from PHP
- PRIMARY HEALTH PROPERTIES PLC - Director/PDMR Shareholding
- PRIMARY HEALTH PROPERTIES PLC - Rule 19.6(c) confirmation with respect to post-offer intention statements regarding Assura plc
- PRIMARY HEALTH PROPERTIES PLC - Retail Investor Presentation via Investor Meet Company
- PRIMARY HEALTH PROPERTIES PLC - Unaudited interim results for the six months ended 30 June 2026
- PRIMARY HEALTH PROPERTIES PLC - Unaudited interim results for the six months ended 30 June 2026
Other Results
- PHPPRIMARY HEALTH PROPERTIES PLC - Unaudited interim results for the six months ended 30 June 2026
- PHPPRIMARY HEALTH PROPERTIES PLC - Unaudited interim results for the six months ended 30 June 2026
- AGLANGLO AMERICAN PLC - Anglo American Interim Results for the Six Months ended 30 June 2026 and Notice of Dividend
- HMNHAMMERSON PLC - Hammerson Half Year Results for the six months ended 30 June 2026
- VALVALTERRA PLATINUM LIMITED - Interim results announcement for the six months ended 30 June 2026 and board committee change